Poster P01
Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology
Federica Di Vincenzo
Università Cattolica del Sacro Cuore, Rome, Italy
Open international conference • Abstract submissions • Registration open
|
Dates: 09–11 June 2027
|
Venue: Barcelona, Spain
Scientific Programme • Keynotes • Oral Presentations • Posters
Agenda EICBPI 2027
The EICBPI 2027 programme brings together keynote lectures, oral and poster research presentations, scientific and translational panels, professional networking, biotechnology innovation, pharmaceutical development and research–industry exchange.
Quick actions
Presenters submit an abstract for review; non-presenting delegates may register directly.
Business Address: 98 Theobalds Rd, London WC1X 8WB, UK
Conference experience
Keynotes • oral presentations • posters • panels • networking
Day 1 • 09 June 2027
Opening & Keynote Programme
Opening remarks, keynote lectures, scientific exchange, translational discussion and networking.
08:30 – 09:00
Registration & Welcome Coffee
Badge collection, informal networking and conference orientation.
09:00 – 09:15
Opening Remarks
Welcome from the organising team and introduction to the scientific programme.
09:15 – 09:45 • Keynote Lecture
Translational Biotechnology & Therapeutic Innovation
Dr Nicola Baker
University of York, United Kingdom
09:45 – 10:15 • Keynote Lecture
Biodiversity, Crop Genetics & Biotech Resilience
Professor Nigel Maxted
University of Birmingham, United Kingdom
10:15 – 10:45 • Keynote Lecture
Inflammation Biology & Drug Discovery Strategy
Prof Paul Moynagh
National University of Ireland, Ireland
10:45 – 11:15
Morning Coffee Break & Networking
11:15 – 11:45 • Keynote Lecture
Cellular Biotechnology & Translational Research
Prof. Carina Baer de Oliveira Mann
Technical University of Munich, Germany
11:45 – 12:15 • Keynote Lecture
Neurogenetics & Molecular Medicine
Dr Sara Anjomani Virmouni
Brunel University London, United Kingdom
12:15 – 12:45 • Keynote Lecture
Cytokine Signalling & Precision Therapeutics
Prof Iris BEHRMANN
University of Luxembourg
12:45 – 13:15 • Keynote Lecture
Epigenomics, Systems Biology & Biotech Innovation
Prof. Dr. Julia Schulze-Hentrich
Saarland University, Germany
13:15 – 14:15
Networking Lunch
14:15 – 14:45 • Keynote Lecture
Agricultural Biotechnology & Applied Bioinnovation
Professor Wei LU
Biotechnology Research Institute, CAAS, China
14:45 – 15:45
Biotechnology & Pharmaceutical Innovation Panel
Translation, therapeutic development, research partnerships, manufacturing readiness and emerging biotechnology opportunities.
15:45 – 16:15
Afternoon Coffee & Networking
16:15 – 17:00
Research–Industry Exchange
Discussion on collaboration, technology transfer, clinical translation, innovation ecosystems and future partnership opportunities.
17:30 – 19:00
Welcome Reception
Informal networking for keynote speakers, presenters, delegates, researchers and industry participants.
Day 2 • 10 June 2027
Keynotes, Oral Presentations & Poster Session
Keynote lectures followed by parallel oral sessions and a dedicated afternoon poster programme.
09:00 – 09:30 • Keynote Lecture
Bioprocess Strategy & Innovation Management
Professor Blaise Kimmel
The Ohio State University, USA
09:30 – 10:00 • Keynote Lecture
Epigenetic Technologies & Molecular Tools
Professor Saulius Klimašauskas
Vilnius University, Lithuania
10:00 – 10:30
Morning Coffee Break & Networking
10:30 – 11:00 • Keynote Lecture
Environmental Biotechnology & Circular Bioeconomy
Professor Piet Lens
Environmental Biotechnology, Germany
11:00 – 11:30 • Keynote Lecture
Pharmaceutical Biotechnology & Forensic Genomics
Professor Dieter Deforce
University of Ghent, Belgium
11:30 – 12:30
Translational Biotechnology & Pharma Development Panel
Therapeutic pipelines, clinical translation, regulatory pathways, bioprocessing, manufacturing and innovation strategy.
12:30 – 13:30
Networking Lunch
13:30 – 15:10
Parallel Oral Presentation Sessions
Research and applied presentations running simultaneously in two conference rooms.
Oral Presentations • Room 1
13:30 – 13:50
Acquisitions, inventors’ turnover, and innovation: Evidence from the pharmaceutical industry
Carmine Ornaghi
University of Southampton, United Kingdom
13:50 – 14:10
The impact of green innovation on corporate social behaviour: longitudinal analysing of the mixed effects on stakeholder relationships
Michele Rubino
University LUM Giuseppe Degennaro, Italy
14:10 – 14:30
Collaboration networks and radical innovation: Two faces of tie strength and structural holes
Jian Wang
Lancaster University Leipzig, The Netherlands
14:30 – 14:50
An Ecosystem Approach to Developing and Implementing a Cocreated Bachelor’s Degree in Digital Health and Biomedical Innovation
Patrícia Alves
University of Porto Rua Dr. Plácido da Costa Porto, Portugal
14:50 – 15:10
Problematic persistence of innovation: Breakdowns and sociotechnical maintenance of the world's most enduring herbicide technology
Shane Hamilton
University of York School for Business and Society, United Kingdom
Oral Presentations • Room 2
13:30 – 13:50
Decades of medicinal plant biotechnology research in South Africa: The success, challenges, and prospects
Nokwanda P. Makunga
Stellenbosch University, South Africa
13:50 – 14:10
Contrasting directionalities in responsible innovation, lessons from the salmon farming industry in Chile and Norway
Joaquin Zenteno Hopp
Western Norway Research Institute, Norway
14:10 – 14:30
Identification of repurposed smart healthcare innovation opportunities for cross-disease applications via dynamic multiplex disease network☆
So Young Sohn
Yonsei University, South Korea
14:30 – 14:50
Where open innovation partnership matters: Phase-specific patterns in R&D project counts for large pharmaceutical firms
Jingning Ao
Morgan State University, USA
14:50 – 15:10
A Highly Efficient Enzymatic Method for the Sustainable and Stereoselective Production of 5α‐H Key Intermediates for Steroidal Pharmaceuticals
Xuejie Qi
Tianjin University of Traditional Chinese Medicine, China
15:10 – 15:40
Afternoon Tea & Coffee Break
15:40 – 17:10
Dedicated Poster Presentation & Discussion Session
Poster presenters will be available beside their posters for discussion, feedback, scientific exchange and networking.
Poster P02
The Gothenburg University Marine Algae Culture Collection (GUMACC): A Nordic resource for marine microalgal research, biotechnology and education☆
Olga Kourtchenko
University of Gothenburg, Sweden
Poster P03
Managing alliance portfolio interdependencies for innovation: The role of governance choice in new alliances
Hans T.W. Frankort
City St George's, University of London, United Kingdom
Poster P04
Why more isn’t always better: Examining the effects of network density on firms’ likelihood of new product innovation
Eric Schaap
Maastricht University, The Netherlands
Poster P05
Patent landscape and innovation trajectories of mRNA vaccine technologies
Surin Hong
Department of Biotechnology, CHA University,
Poster P06
Long-term performance of technology acquisitions: The role of acquisition program diversity, innovation, and alliance portfolio size – Evidence from the pharmaceutical industry
Lars Schweizer
Strategic Management, Goethe University, Germany
Poster P07
Privatizing and prescribing identity: How Canadian biotechnology firms capture queer, trans, and neurodivergent movements for profit
Megan Q. Linton
Carleton University, Canada
Poster P08
Analyzing the impact of open innovation on the innovation performance of Korean biopharmaceutical firms in bio-clusters: Focus on characteristics of bio-clusters
Dohyoung Kim
Kookmin University, Republic of Korea
Poster P09
A cloud-enabled digital twin platform for upstream processing in biotechnology: Integrating CFD, compartmentalization, and reaction kinetics
Xiyan Li
Technical University of Denmark, Denmark
Poster P10
Research on the relationship between R&D investment, corporate governance and corporate performance --an empirical analysis based on listed pharmaceutical manufacturing enterprises
Dongqi Wan
The Affiliated Pu'er Hospital of Kunming University of Science and Technology, China
Poster P11
From lab to fork: Directionality in the European innovation system for precision fermentation-derived food ingredients
Paul Plummer
Uppsala University, Sweden
Poster P12
Impact of China’s drug innovation policy on patent quantity and quality: Evidence from a representative chemical pharmaceutical enterprise
Yifan Wu
Shenyang Pharmaceutical University, China
Poster P13
Does convergence in firms’ innovation capability accumulation paths drive industrial convergence and energy transition? An empirical exploration
Paulo N. Figueiredo
Getulio Vargas Foundation (FGV), Brazil
Poster P14
Why is the pharmaceutical industry investing in targeted therapies? The emergence of “premium pharma”
Paul A. Martin
The University of Sheffield, Sheffield, United Kingdom
Poster P15
Impact of the FDA roadmap and perspectives for regulatory use of new approach methodologies in Japanese pharmaceutical companies
Tetsuro Araki
Japan Pharmaceutical Manufacturers Association (JPMA), Japan
17:10 – 17:30
Networking & Day Summary
19:00 – 21:00
Networking Dinner
Optional conference dinner for registered participants who selected the dinner add-on.
Day 3 • 11 June 2027
Oral Presentations & Closing Programme
Parallel speaker sessions, interdisciplinary discussion and conference closing.
09:00 – 11:40
Parallel Oral Presentation Sessions
Scientific, innovation, policy, biotechnology and pharmaceutical research presentations.
Oral Presentations • Room 1
09:00 – 09:20
Exploration versus exploitation: The innovation propensity of academic spin-offs during the sustainable returns phase
Yang Ye
Southwestern University of Finance and Economics, China
09:20 – 09:40
Quality-by-design as the pharmaceutical innovation paradigm: mapping the field and proposing a conceptual framework
Vesna Vlaisavljevic
Facultat d’Economia i Empresa, Universitat de Barcelona, Spain
09:40 – 10:00
Prevention and protection of health and the environment in laboratories using advanced and innovative biotechnological methods: results of an Italian project
E. Sturchio
Department of Technological Innovation, Italy
10:00 – 10:20
Innovations and challenges in the use of cactus mucilage: A technological analysis
Deborah Murowaniecki Otero
Federal University of Bahia, Brazil
10:20 – 10:40
Mapping global research in the field of health biotechnology for the period 1990–2023. A bibliometric analysis
Juan Díaz Amorin
Universidad Nacional Mayor de San Marcos, Peru
10:40 – 11:00
Innovations in response to the COVID-19 pandemic: The role of non-profit and public institutions
José Alberto Solis-Navarrete
Universidad Nacional Autónoma de México, México
11:00 – 11:20
Global innovation landscape of Ganoderma mushrooms: Integrating patent mapping, technological life cycle modeling, and an LLM keyword extraction
Marlon Oliveira Alves Foffano
Federal University of Rio de Janeiro (UFRJ), Brazil
11:20 – 11:40
Sustainable repurposing of grape marc: Potential for bio-based innovations
Mohammad J. Taherzadeh
Högskolan i Borås, Sweden
Oral Presentations • Room 2
09:00 – 09:20
Mergers and acquisitions as drivers of business model innovation in the U.S. medical device industry: Evidence from 101 Cases (2018–2024)
Dongwoo Kim
Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Korea
09:20 – 09:40
A New Biotechnology Era: Computer Science Enabled Solutions to Environmental Challenges in Agriculture
Claire Dinn
Acadia University, Canada
09:40 – 10:00
International approval of Chinese pharmaceuticals: a USA-anchored analysis with comparative insights from Europe and other markets
Zhihao Xu
Wuhan University, China
10:00 – 10:20
Research evolution on project management in the pharmaceutical sector: a systematic literature review
Kamil Mroz
HEC Liège – University of Liège, Belgium
10:20 – 10:40
Australia's vaccine legacy: Time for a boost? Mapping an innovation system in a fragmented data environment
Linda H.M. van de Burgwal
Athena Institute, Vrije Universiteit Amsterdam, Netherlands
10:40 – 11:00
Bioeconomy innovations and their regional embeddedness: Results from a qualitative multiple-case study on German flagship innovations
Michael P. Schlaile
Hochschule für Gesellschaftsgestaltung (HfGG), Germany
11:00 – 11:20
An incomplete contract analysis of innovation management: “Open vs. closed” innovation in a dynamic framework
Yutaka Suzuki
Hosei University, Japan
11:40 – 12:00
Coffee Break
12:00 – 13:00
Future Biotechnology & Pharmaceutical Innovation Forum
Emerging technologies, responsible innovation, global collaboration, research translation and future conference priorities.
13:00 – 14:00
Networking Lunch
14:00 – 14:30
Closing Remarks & Conference Conclusion
Closing acknowledgements, certificates and post-conference information.